Recalls and suspensions

Subscribe to TGA safety information
2 August 2021
Recall - Possible presence of benzene
16 July 2021
Update - further information for consumers
3 June 2021
Product Defect Alert - child-resistant caps may not function correctly
21 May 2021
Recall due to unacceptable risk in pregnancy

More safety information »

Safety information

Subscribe to TGA safety information
5 August 2021
Information about the TGA's safety monitoring of COVID-19 vaccines.
5 August 2021
TGA investigation – potential low levels of contamination with N-nitrosovarenicline
4 August 2021
Clinical guidelines for tocilizumab (Actemra) have been published to help manage the shortage.
2 August 2021
Black Ant King tablets pose a serious risk to your health and should not be taken.

More safety information »

News

Subscribe to TGA latest news and updates
6 August 2021
The public consultation for the Proposed changes to Required Advisory Statements for Medicine Labels (Chlorhexidine, hydrocortisone, ibuprofen) is now open.
6 August 2021
The public consultation for the Proposed changes to Required Advisory Statements for Medicine Labels (Melatonin) is now open.
6 August 2021
The public consultation for the Proposed changes to Required Advisory Statements for Medicine Labels (Triptans) is now open.
6 August 2021
The public consultation for the Proposed changes to Required Advisory Statements for Medicine Labels (Mometasone) is now open.

More news »